EP1694139A1 - Procede de production de preparations de substances minerales a constituants multiples - Google Patents

Procede de production de preparations de substances minerales a constituants multiples

Info

Publication number
EP1694139A1
EP1694139A1 EP04803277A EP04803277A EP1694139A1 EP 1694139 A1 EP1694139 A1 EP 1694139A1 EP 04803277 A EP04803277 A EP 04803277A EP 04803277 A EP04803277 A EP 04803277A EP 1694139 A1 EP1694139 A1 EP 1694139A1
Authority
EP
European Patent Office
Prior art keywords
primary
oxidative treatment
temperature
mineral
thermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04803277A
Other languages
German (de)
English (en)
Inventor
Andreas Noack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1694139A1 publication Critical patent/EP1694139A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9741—Pteridophyta [ferns]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Definitions

  • the present invention relates to a method for producing multicomponent mineral preparations.
  • plant minerals especially via ashing processes, for health reasons.
  • plant minerals have the advantage of containing a broader and more homogeneous mineral spectrum, whereby the basic concept ensures that there is hardly any risk of overdosing individual minerals as long as a respective dose corresponds to a nutritionally reasonable amount of the corresponding plant.
  • JP 04016164A describes the preparation of mineral preparations based on incinerated organic substances, the ash being extracted either acidically basic or neutral.
  • the problem of pollutants in the ashing process nor the ways in which the non-extractable mineral content can be increased are discussed.
  • a plant with the name Salicornia is extracted according to JP 2001292725A with hot water, and the extract is then dried and incinerated for 4 hours.
  • the object of the present invention is to create a multicomponent mineral preparation which is as complete as possible, that is to say contains all the minerals which guarantee and strengthen the vitality of our body and which is free from substances which are harmful to health and which is the specification of a corresponding process. It is essential that the absence of pollutants must already be ensured in the manufacturing process, since, for example, a crystallization process cannot be applied as a cleaning stage, since important trace elements / minerals would be lost.
  • primary thermal-oxidative treatment is also abbreviated as primary oxidation, secondary thermal-oxidative treatment as secondary oxidation, the product of the primary thermal-oxidative treatment as primary oxidate and the product of the secondary thermal-oxidative treatment as secondary oxidant.
  • the primary thermal-oxidative treatment corresponds to the usual ashing, with the focus in terms of process technology being on extracting the ash or the primary oxidate as much as possible in powder form and therefore setting the furnace parameters in such a way that the autothermal operation is as far as possible with a safe distance from the Ash melting temperature is removed in order to be able to use combustion furnaces.
  • the secondary thermal-oxidative treatment has the goal, on the one hand, of lowering or minimizing the proportion of residual organic compounds and coked carbon below an unhealthy level beyond an autothermal mode of operation, and, on the other hand, converting insoluble constituents of the primary oxidate into rudimentarily soluble species.
  • the insoluble components in particular contain valuable trace and ultra-trace elements, which are to be meaningfully solubilized with the highest possible yield. It has been shown here that process conditions are extremely useful in which the sintering together or melting of powder particles takes place and these rudimentarily soluble species arise in an increased yield.
  • the term “rudimentarily soluble species” is understood to mean those species which become soluble or colloidally soluble by adding acid to the secondary oxidate, in particular citric acid.
  • the secondary thermal-oxidative treatment is usually carried out at a higher temperature than the primary thermal-oxidative treatment, typically at least 10 ° C., preferably at least 30 ° C. and particularly preferably at least 50 ° C. above the temperature of the primary thermal-oxidative treatment. In individual cases, however, it can also exceed 200 ° C. above the temperature of the primary thermally. oxidative treatment.
  • the granulate and / or the melt which tends to form in the secondary thermal-oxidative treatment is ground again.
  • the acid solubility can be increased to at least 95%, preferably at least 98% and particularly preferably to over 99%, which in turn causes a priori poorly soluble species to be disproportionately solubilized and bioavailable.
  • EP 0 891718 - Example 1 - at most 90% solubility of the ash constituents in acid is obtained in a conventional ashing, even with raw materials with a relatively high soluble ash content,
  • a combustion temperature that produces a powdered and free-flowing primary oxidate.
  • the selected temperature can be between 500 ° and 3000 ° C, preferably between 600 ° C and 1200 ° C, particularly preferably between 750 ° C and 1050 ° C.
  • the primary oxidate typically has a maximum of 30%, preferably a maximum of 10% and particularly preferably a maximum of 3% of the original carbon content as organically bound carbon.
  • the primary oxidate is generally cooled, sieved - typically with a sieve size of less than 1 mm, preferably less than 0.2 mm, optionally temporarily stored and transported to a second temperature treatment zone.
  • the local separation of the two temperature treatment zones can take place within the framework of a higher-level system that integrates these two zones, but also at two completely different production locations.
  • Special animals or parts of animals such as bones or special organs are less preferred, but quite possible.
  • the use of special plants or animal parts is interesting because one wants to use the "natural" enrichment of some trace elements for therapeutic purposes.
  • Grasses of certain mountain meadows that have not been intensively farmed up to now and seaweed are considered to be particularly valuable raw materials
  • Leaves such as olive tree leaves, maple leaves, birch leaves, nettle, aloe vera, thyme etc. also represent high-quality raw materials.
  • Root and root parts for example of game and / or forest herbs, ginseng etc. are particularly preferred.
  • mushrooms and mushroom root are particularly preferred.
  • the secondary thermal-oxidative treatment is preferably carried out quasi-continuously in a push-through furnace, a roller furnace or a belt furnace. It can also be carried out continuously in an externally heated rotary tube or in an externally heated tube with screw conveyor. In contrast to the primary thermal-oxidative treatment, the secondary thermal-oxidative treatment is controlled by external heating sources, optionally also by microwaves.
  • the method can be carried out both in batch mode with two different heating zones, but preference is given to at least partially continuous process control, the secondary oxidation preferably being operated continuously.
  • the method according to the invention further comprises a variant according to which the plants are already primary oxidized at the place of harvest, the primary oxidate to the place of Secondary oxidation is transported and processed there according to the procedure outlined.
  • the secondary thermal-oxidative treatment can be carried out in normal air, but advantageously with enriched or pure oxygen and / or water vapor.
  • enriched oxygen or water vapor atmosphere is on the one hand the higher oxidative potential of the atmosphere, which supports the oxidation of the a priori inert noble metals, which thus become more bioavailable. It also counteracts the formation of nitrogen oxides, which can otherwise have a considerable toxicological impact on the product.
  • the simplest form of grinding can already be carried out in a mortar or a ball mill.
  • the grinding process can be carried out dry, but it is advantageous to use a wet process, which can generally reduce the particle size even more. Also a dry u.
  • Combine wet grinding process wet grinding is preferably carried out in a pH range between 8 and 16, particularly preferably between 10 and 14. In this pH range, the ground material has the slightest tendency to agglomerate.
  • the grinding energies to be introduced for a pearl mill are between 0.1 and 10 Wh / kg.
  • Organic materials can also be added to the mill base, in particular citric acid, malic acid, ascorbic acid, lactic acid, acetic acid and tartaric acid, and mixtures of the like.
  • the powder in the case of a dry grinding, can advantageously be filled into capsules / gelatin capsules or compressed into tablets with a binder, preferably milk sugar.
  • a binder preferably milk sugar.
  • the mineral preparations according to the invention can be used as food supplements, food additives, cosmetics, medicaments, and the intake can take place either orally, by inhalation, intravenously, rectally or externally.
  • Correspondingly produced mineral preparations can of course be mixed with other minerals, whereby at least 2% of the mineral preparation according to the invention is usefully mixed into commercially available mineral preparations, which significantly increases the balance of commercially available preparations.
  • any food with admixtures of mineral preparations according to the invention can also be upgraded in quality.
  • Minerals that are produced by the method according to the invention are also recommended as a broad-spectrum agent for those cures for colloidal silver becomes.
  • Preparations produced according to the invention are particularly effective in the following indications: heavy metal poisoning, chronic nausea, migraines, allergies, cardiovascular diseases, high blood pressure. Experts observe a strong connection between the lack of trace elements and the occurrence of the disease.
  • body fluids are alkalized, ie the body pH increases and slags are released - it follows: good regulation of blood pressure; prophylactic effect against cardiovascular diseases; increase in the flow of oxygen to the cells; increase in body energy - increase in health and fitness levels.
  • the current state-of-the-art mineral preparations are mainly mixed together from individual salts.
  • the basis of the mixture composition is the assumption that a certain intake of the essential minerals present in the body in a fixed dose makes sense; In the final analysis, however, the determination of the mixture composition is rather arbitrary, since the medical know-how does not go far enough to make generally definite dose recommendations for trace elements.
  • Trace elements such as zinc, molybdenum, chromium, gold, rhodium, platinum, nickel, cobalt, iridium, osmium are generally not taken into account in mineral preparations, so that in the case of a "synthetic" combination of salts of different origins, the trace elements are always administered in an unnatural dose , especially in relation to the "primary minerals" such as calcium, magnesium, potassium. While there are many opinions about optimal dosage of minerals, mixing them together is a science in itself; the knowledge required for this fills entire volumes of special literature. In particular, the influence of trace elements on our health and well-being is very difficult to estimate; the possibilities of absolute as well as relative dosing of the trace elements with each other are almost unlimited.
  • minerals in particular have the task of keeping the body pH value as high as possible in order to prevent chronic acidosis under which more than 80% of the population in industrialized countries indirectly or counteracting directly and which is the cause of cardiovascular diseases, fungal diseases, parasites and a reduced activity of the immune system, acidosis is the nutritional accumulation of acid in the body fluids mainly of the lymph; strongly acid-forming foods from which minerals have been removed, white flour and sugar are the cause.
  • molybdenum is considered an antagonist for cobalt
  • copper in turn is considered an antagonist for zinc; see: A beginnerers Introduction to Trace Minerals, Erwin Dicyan Keats Puplishing, Inc.New Canaan, Connecticut / USA.
  • mineral preparations can be produced simply by ashing organic or vegetable materials. The corresponding preparation is then simply produced from plant materials by a discontinuous temperature treatment up to 920 ° C.
  • the discontinuous and one-step ashing method used in the prior art also results in a large temperature gradient within the ashing sample. This either leads to adsorption of pollutants in cold nests or to incomplete oxidation of the raw material; Both effects can ultimately render the entire product unusable do.
  • the appropriate process technology therefore has a decisive influence on whether the product is health-promoting or rather toxic. In no way does the stated state of the art refer to contamination by nitrates / nitrites and residual organic components.
  • Another problem with the prior art is the bioavailability of the trace minerals, which, according to experts, is particularly large if they are present in the metallic state as a colloid. Some experts suspect that a cluster size between 10 and 100 atoms represents an optimum for our organism. This is not dealt with in the prior art.
  • JP 04016164A describes the preparation of mineral preparations based on incinerated organic substances, the ash being extracted either acidically basic or neutral. However, the issue of pollutants in the ashing process is not dealt with.
  • a plant with the name Salicornia is extracted according to JP 2001292725A with hot water, and the extract is then dried and incinerated for 4 hours.
  • the procedural solution for pollutant-free ashing is absolutely critical dependent on the clean product not being contaminated with semi-finished material; the complexity is that the intermediate product, the primary oxidized material, is highly toxic and any contamination of the end product must be excluded; ie the transport of the mineralized product in the process must be completely controllable and reproducible.
  • a significant advantage of the preparations according to the invention is that freedom from harmful substances is already ensured in the manufacturing process, since, for example, a crystallization process does not have to be applied as a cleaning stage, since important trace elements / minerals would be lost in the process.
  • the method according to the invention for producing pollutant-free multicomponent mineral preparations contains in particular the following steps: a. Primary oxidation of organic raw materials, of plant or animal origin, in a primary temperature treatment zone; b. Conditioning the primary oxidized material; c. Transporting the primary oxidized material to a secondary temperature treatment zone; d. Secondary oxidation of the primary oxidized material in a secondary temperature treatment zone.
  • the invention also includes an apparatus for producing mineral preparations with the features a. a device for the entry of primary oxidized material of plant or animal origin, b. a conveyor unit with which the primary oxidized material is transported, c. a transport channel in which the primary oxidized material is transported, d. a heating zone, e. an exhaust duct.
  • the primary oxidation is carried out in a temperature range of 500 to 3000 ° C, preferably the organic material is oxidized at 500 - 1500 ° C with air.
  • a maximum of 40%, preferably a maximum of 10% of the original carbon content is retained as organically bound carbon.
  • the continuous or quasi-continuous mode of operation is advantageous in the device according to the invention or in the method, at least in the secondary oxidation.
  • Quasi-continuously in the sense of the description of the invention means that the primary oxidized material can also be transported or pushed through the secondary oxidation stage in batches.
  • the conditioning of the primary oxidized material for the secondary oxidation stage is advantageous.
  • a very homogeneous powder mix is required in order to finally achieve a very uniform residence time in the secondary oxidation.
  • a process can ultimately be designed that enables the product to be free of pollutants with reasonable effort.
  • An important fluid-dynamic parameter is the flow behavior of the oxidizing gas. This flows through defines the powder matrix of the primarily oxidized material, the gas flow rate being between 1 mm / s and 4 m / s, preferably between 2 cm / s and 1m / s
  • the conveyor unit with which the primary oxidized material enters the secondary temperature treatment zone conditions it by pressing it, whereby a pressure between 1 kPa and 10,000 kPa is built up. This conditioning / pressing is important for the uniform residence time behavior as well as for the defined flow through the mineral matrix of the waste gases arising in the secondary oxidation.
  • the conditioning of the primary oxidized material is optionally carried out by sieving off the coarser particles which might not be fully implemented in the secondary oxidation. It is advantageous to choose a sieve so that only particles smaller than 1 mm, preferably smaller than 0.2 mm, can enter the secondary temperature treatment zone.
  • the temperature of the primary oxidate drops by at least 50 ° C., preferably by at least 100 ° C. and particularly preferably by at least 300 ° C.
  • the primary oxidation is reduced in volume by at least 65%, preferably by at least 80%, which greatly simplifies handling and controllability in the process in the subsequent processing.
  • the term primary oxidate is understood as the intermediate product between the temperature maximum of the primary and the temperature maximum of the secondary oxidation stage. After passing through the second temperature maximum, the product is referred to as secondary oxidate.
  • the secondary oxidation is preferably carried out in an externally heated tube or annular gap in which the primary oxidate is moved in a tube, for example by a rotating screw conveyor.
  • a slide or piston slide system is also suitable as a transport system, but also a rotating tube, which combines the delivery unit, transport channel and heating zone when it is heated at the same time. It is advantageously heated from the outside, but direct injection of fuel gases in excess oxygen is also possible.
  • the device is optionally provided with a gas supply, by means of which the corresponding oxidation gas / mixture is introduced into the oxidation region in a defined manner.
  • the quality of the end product is determined in particular by the residence time behavior and the flow rate of the primary oxidate in the secondary temperature treatment zone.
  • This throughput rate for a fly ash oxidation process is between 0.1 and 4 m / s, for a fluidized bed process between 0.01 m / h and 3 m / min, preferably between 1 m / h and 1 m / min.
  • the layer thicknesses vary between 1 mm and 50 cm, preferably between 5 mm and 5 cm.
  • typical residence times in the secondary temperature treatment zone are between 0.1 s and 2 min, preferably between 0.5 and 60 s.
  • the primary oxidation can be carried out in the same device as the secondary oxidation.
  • primary oxidation can, however, also be carried out at a completely different location, for example at the location of the harvest of the vegetable starting materials. So you can optimize the transport effort to a central secondary oxidation plant.
  • the period between primary and secondary oxidation is therefore preferably greater than one day; however, if the primary oxidation is carried out continuously, the interval can also be only a few seconds, preferably at least 5 s.
  • poorly soluble calcium carbonate can be retained in the slurry or extraction process by the defined addition of CO2 or alkali carbonates, bicarbonates, which ultimately significantly improves the solubility of the mineral preparation even at high doses in the body and thus the so-called calcification of blood vessels or the formation of kidney , Urine and gallstones.
  • a last process step can optionally be used, which drastically increases the bioavailability of the trace elements in particular.
  • the following elements are to be regarded as trace minerals in accordance with their chemical shorthand: Li, Rb, Cs, Be, Sr, Ba, Sc, Y, La, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Re, Fe, Ru, Os, Co, Rh, lr, Ni, Pd, Pt, Cu, Ag, Au, Zn, Cd, Ga, In, TI, Ge, Sn, As, Sb, Bi, Se, Te, Ce, Pr, Sm, Eu, Gd, Tb, Yb, Lu.
  • the aqueous basic, neutral or acidic solution is optionally treated with at least one reducing agent.
  • reducing agents are hydrogen, sulfur dioxide, hydrazine, glucose, aldehydes, milk sugar etc.
  • the bubbling of hydrogen into the corresponding solution has proven to be advantageous. It is sunny if you add an appropriate vaccine colloid to the solution, which significantly speeds up the reduction process.
  • These solutions have a redox potential of + 0.0 V to 2.0 V, preferably from +0.1 V to 1.5 V, particularly preferably from 0.2V to 1 V, compared to a normal hydrogen electrode.
  • the cluster size can be controlled via the reduction time.
  • the clusters of preparations according to the invention consist of 5 to 1,000,000 atoms / ions, preferably from 10 to 8,000 and particularly preferably from 12 to 600.
  • the mean diameter of the clusters is between 0.3 nm and 500 nm, preferably between 0.7 and 100 nm
  • These clusters can consist of one or more trace elements.
  • the solution can either be evaporated and used in various ways as a salt or powder. Or the colloidal solution is applied directly, e.g. taken orally.
  • the cluster size or the size of the colloidal particles can be determined, inter alia, using the light scattering on the colloidal solution.
  • Other methods for determining the cluster size are determining the sedimentation rate in an ultracentrifuge, preferably with optical measuring instruments, and electrophoresis.
  • the method can be carried out both in batch mode with two different heating zones, but preference is given to at least partially continuous process control, the secondary oxidation preferably being operated continuously.
  • An embodiment is shown in Figure 1.
  • the primary oxidized material is transported by a rotating screw and pushed through a vertically arranged heating zone.
  • the heating zone can be heated to a temperature between 300 and 3000 by electrical resistances or also inductively or even by electromagnetic radiation or by gas or oil firing ° C.
  • oxygen or oxygen-enriched air the O2 partial pressure in the primary oxidized material is increased, which reduces the necessary temperature in the heating zone and on the other hand considerably reduces the formation of NOx, which in the end, in connection with the resultant, greatly uniform and narrow residence time spectrum results in a very low nitrate / nitrite concentration of the end product.
  • direct heating with gas can also be carried out, preferably with a hydrogen / oxygen mixture, in which case the dust of the primary oxidized material is oxidized.
  • this method is more complex from a procedural point of view, since the secondary oxidized material has to be separated out from a much higher volume flow and, moreover, it is more energy-intensive.
  • the primary oxidation is not technically complex. In principle, this can be done in a simple oven or in a fireplace. The only important thing here is that the ashing process has largely been completed. Only then is it possible to carry out the secondary oxidation in a process-technical manner and to coordinate the simultaneous transport of primary / secondary oxidate and exhaust gases.
  • Another major advantage of the process is that the process can be easily controlled and controlled. Since the exhaust gas flows completely through the powder matrix of the secondary oxidate, the pollutant load in the exhaust gas also contributes to this the pollution of the product. For this reason, very specific product monitoring can also be achieved by means of appropriate gas analysis, preferably a gas chromatograph with a connected mass spectroscopic detector, based on the exhaust gas monitoring.
  • the method according to the invention further comprises a variant, according to which the plants are already primary oxidized at the point of harvest, the primary oxidate is transported to the location of the secondary oxidation and is further processed there in accordance with the method described.
  • the ratio of the sum of potassium and sodium ions to the nitrate concentration can easily be used for the quality of the product.
  • the latter can be easily analyzed by reducing the nitrate to nitrite and then adding sulfanilic acid.
  • the intense coloring of the resulting azo dye makes it easy to determine the nitrate content.
  • a high-quality preparation has a (Na + K) / (NO3) ratio (in short: NaKNO) greater than 1,000, preferably greater than 10,000 and particularly preferably greater than 100,000. With a simple incineration of plant components, NaKNO values greater than 1000 are not possible. Using the method according to the invention, in particular if pure oxygen is flowing into the temperature treatment zone, NaKNO values between 10,000 and 100,000 were determined.
  • Another feature of the product is the ratio of potassium + nartium to organically bound carbon: carbon compounds that have survived these high temperatures during manufacture are hardly biodegradable and are usually highly toxic. These organic residues are determined using the methods common in organic chemistry for the field of trace analysis.
  • Correspondingly produced mineral preparations can of course be mixed with other minerals, whereby at least 2% of the mineral preparation according to the invention is usefully mixed into commercially available mineral preparations, which significantly increases the balance of commercial preparations.
  • any food with admixtures of mineral preparations according to the invention can also be upgraded in quality.
  • Minerals that are produced by the method according to the invention are also suitable as a broad-spectrum medication for those cures for which colloidal silver is recommended.
  • Preparations produced according to the invention are particularly effective in the following indications: heavy metal poisoning, chronic nausea, migraines, allergies, cardiovascular diseases, high blood pressure. Experts observe a strong connection between the lack of trace elements and the occurrence of the disease.
  • body fluids are alkalized, ie the body pH increases and slags are released - it follows: good regulation of the Blood pressure; Prophylactic effect against cardiovascular diseases; Increasing the flow of oxygen into the cells; Increase in body energy - increase in health and fitness levels.
  • a device consisting of a screw conveyor, with a 5 cm long spiral, with a diameter of 20 mm, which feeds a tube, with an inner diameter of 22 mm.
  • the pipe runs approx. 80 mm horizontally and is then bent upwards, the vertical portion being approx. 800 mm.
  • the vertical part is surrounded by a tube furnace; Height approx. 500 mm, pipe diameter 40 mm.
  • a distributor is screwed on, which discharges the primary oxidate downwards with cooling according to Figure 1 and discharges the exhaust air upwards into a fume cupboard.
  • the internal temperature is determined approximately in the middle of the tube via a thermocouple introduced into the heating zone.
  • the composition of the exhaust air is determined via a GC connected to the exhaust air duct with a mass spectrometer.
  • a method for producing pollutant-free multicomponent mineral preparations comprising the following steps: a. Primary oxidation of organic raw materials, of plant or animal origin, in a primary temperature treatment zone; b. Conditioning the primary oxidized material; c. Optional transport of the primary oxidized material to a secondary temperature treatment zone; d. Secondary oxidation of the primary oxidized material in a secondary temperature treatment zone.
  • the method according to at least one of the aforementioned points characterized in that gas flows through the matrix of the primary oxidate in the secondary temperature treatment zone 5.
  • the method according to at least one of the aforementioned points characterized in that in a fluidized bed process the throughput speed of the primary oxidate through the 2nd temperature treatment zone is preferably between 1 m / min and 1 m / h. 20.
  • the method according to at least one of the aforementioned points characterized in that the material which has undergone the secondary oxidation, in particular for cluster production, is partially dissolved or extracted in basic, neutral or acidic aqueous solutions.
  • Device for the production of mineral preparations comprising a. a device for the entry of primary oxidized material of plant or animal origin, b. a conveyor unit with which the primary oxidized material is transported, c. a transport channel in which the primary oxidized material is transported, d. a heating zone, e. an exhaust duct. 26. The device according to at least one of the above points, characterized in that the heating zone is heated to a temperature between 300 ° C and 3000 ° C.
  • the device according to at least one of the aforementioned points, characterized in that it additionally comprises a gas supply.
  • the device according to at least one of the aforementioned points characterized in that the heating zone is heated indirectly, with gas and / or electrically.
  • the device according to at least one of the aforementioned points characterized in that the primary oxidized material has a dwell time of 5 s to 48 h in the hot zone.
  • Device Device according to at least one of the aforementioned points, characterized in that the delivery unit, transport channel and heating zone are combined in a heated rotary tube.
  • the heating zone is a channel, i.e. represents a tube or an annular gap.
  • the primary oxidized material Has layer thickness between 1 mm and 50 cm, preferably between 5 mm and 5 cm.
  • the primary oxidized material has a contact time in the hot zone of 0.1 s - 5 min, preferably between 0.5 s and 60 s.
  • the conveying device is a rotary tube or a screw conveyor or sliding element.
  • Mineral substance preparations can be produced or produced according to a method according to items 1-24, characterized in that they have a (K + Na) / C (organic) mass ratio> 100, preferably> 1,000 and particularly preferably> 10,000.
  • Mineral preparations can be produced or produced according to a method according to items 1-24, characterized in that they contain trace elements in colloidal form.
  • Mineral preparations according to at least one of the aforementioned points, characterized in that they have a (K + Na) / nitrate ratio> 1000, preferably> 10,000 and particularly preferably> 100,000.
  • Mineral preparations according to at least one of the aforementioned points characterized in that they have a redox potential of + 0.0 V to 2.0 V, preferably of +0.1 V to 1.5 V, particularly preferably of 0.2 V, in aqueous solution up to 1 V compared to a normal hydrogen electrode.
  • Mineral preparations according to at least one of the aforementioned points characterized in that they contain clusters of trace elements.
  • Mineral preparations according to items 38 - 45, characterized in that they are mixed or mixed to a maximum of 98% with other minerals and salts or corresponding mineral mixtures in aqueous or alcoholic solutions.
  • Mineral preparations can be produced or produced according to at least one of items 1 to 24, and can be used as food supplements, food additives, cosmetics, medicaments, and the intake can take place either orally, by inhalation, intravenously, rectally or externally.
  • the following elements are to be regarded as trace minerals according to their chemical shorthand: Li, Rb, Cs, Be, Sr, Ba, Sc, Y, La, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Re , Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt, Cu, Ag, Au, Zn, Cd, Ga, In, TI, Ge, Sn, As, Sb, Bi, Se, Te, Ce , Pr, Sm, Eu, Gd, Tb, Yb, Lu.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne un procédé de production de préparations de substances minérales à constituants multiples pauvres en substances nocives ou exemptes de substances nocives, procédé selon lequel des matières animales ou végétales sont utilisées et au moins deux différentes étapes de traitement par oxydation thermique sont exécutées en des points séparés. Les préparations de substances minérales produites selon l'invention se caractérisent en ce qu'elles contiennent essentiellement les substances minérales extraites du sol par la plante concernée sous forme hautement biodisponible, tout en présentant une très faible teneur en composés organiques modifiés thermiquement. Des éléments traces a priori peu solubles sont donc présents de préférence sous forme colloïdale, c'est pourquoi l'assimilation biologique est particulièrement élevée. Ces préparations de substances minérales sont largement plus avantageuses que les préparations de substances minérales disponibles aujourd'hui du point de vue de leur effet sur la santé et sur la condition physique, puisque ces préparations contiennent aussi tous les éléments traces qui ne peuvent pas être décelés par des analyses mais peuvent néanmoins exercer un effet énergisant important sur notre organisme.
EP04803277A 2003-11-25 2004-11-25 Procede de production de preparations de substances minerales a constituants multiples Withdrawn EP1694139A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10355400A DE10355400A1 (de) 2003-11-25 2003-11-25 Multikomponenten Mineralstoffpräparate und Verfahren zur Herstellung von Multikomponenten-Mineralstoffpräparaten
PCT/EP2004/013391 WO2005051104A1 (fr) 2003-11-25 2004-11-25 Procede de production de preparations de substances minerales a constituants multiples

Publications (1)

Publication Number Publication Date
EP1694139A1 true EP1694139A1 (fr) 2006-08-30

Family

ID=34625290

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04803277A Withdrawn EP1694139A1 (fr) 2003-11-25 2004-11-25 Procede de production de preparations de substances minerales a constituants multiples

Country Status (5)

Country Link
US (1) US20080014291A1 (fr)
EP (1) EP1694139A1 (fr)
JP (1) JP2007522101A (fr)
DE (1) DE10355400A1 (fr)
WO (1) WO2005051104A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005027333B4 (de) * 2005-06-13 2017-04-13 Terra Nano Ltd. Nanoskalische Reaktivdesorption - ein Verfahren zur Herstellung kolloidalisierter Wirkstoff- oder Vitalstoffspezies, insbesondere entsprechender Wirkstoff- oder Vitalstoffkonzentraten sowie Vorrichtungen zur Durchführung derselben
WO2009147467A2 (fr) * 2008-06-06 2009-12-10 Yossi Paley Remède entièrement naturel contre la migraine
JP5467858B2 (ja) * 2009-12-24 2014-04-09 有限会社サニーヘルツジャパン 食肉加工食品の品質改良剤
JP2013000003A (ja) * 2011-06-12 2013-01-07 Yoshiro Nagado 灰化玄米製品および玄米ミネラル飲料とその製造方法
US10517319B2 (en) 2015-04-09 2019-12-31 Kazumi ISHINO Method of preparing mineral supplementing agent, and mineral supplementing agent
FR3040881B1 (fr) * 2015-09-10 2019-05-24 Laboratoire Nutergia Procede d'obtention d'un concentre de mineraux marins
WO2019044042A1 (fr) * 2017-08-28 2019-03-07 杉山　修 Batterie ayant une solution électrolytique contenant de l'eau minérale alcaline ionisée, matériau actif d'électrolyte et procédé de production d'une solution électrolytique de batterie
US12097232B1 (en) 2024-01-26 2024-09-24 King Faisal University Method of preventing cadmium-induced renal toxicity using a plant product derived from Achillea millefolium L

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1729162A (en) * 1921-04-22 1929-09-24 Oscar L Barnebey Manufacture of vegetable char
KR900001844B1 (ko) * 1987-07-21 1990-03-24 강권중 위생 재제재염의 제조방법
DE3727417A1 (de) * 1987-08-17 1989-03-02 Pharm Elan Gmbh Verfahren zum herstellen eines mineralstoffgemisches fuer diaetetische oder pharmazeutische zwecke
DK546289D0 (da) 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
JPH0716382B2 (ja) * 1990-05-10 1995-03-01 森下仁丹株式会社 海藻ミネラルの製造方法
DE4414579C1 (de) * 1994-04-27 1995-09-14 Clemens Dr Kiefer Verfahren und Vorrichtung zur Vergasung und Wärmeerzeugung
DE69702311T2 (de) * 1997-12-23 2001-02-22 Aboca Di Mercati Valentino & C. S.A.S., Sansepolcro Konzentrierter, mineralisierter, natürlicher Komplex zur Integration von Mineralstoffen und Spurenelementen und Verfahren zur Herstellung desselben
DE19856432A1 (de) 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
DE19919751A1 (de) 1999-04-29 2000-11-09 Basf Ag Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthophyllen, deren Herstellung und Verwendung
KR100448673B1 (ko) * 2000-02-22 2004-09-16 홍영표 식물성 소금의 제조방법 및 식물성 소금
DE10104494A1 (de) 2001-01-31 2002-08-01 Basf Ag Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide
DE10214031A1 (de) 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
US20040126460A1 (en) * 2002-08-01 2004-07-01 Schrauzer Gerhard N. Nutritional mineral supplements from plant ash

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2005051104A1 *

Also Published As

Publication number Publication date
JP2007522101A (ja) 2007-08-09
DE10355400A1 (de) 2005-07-07
US20080014291A1 (en) 2008-01-17
WO2005051104A1 (fr) 2005-06-09

Similar Documents

Publication Publication Date Title
EP1720419A2 (fr) Solutions sursaturees et nanometriques de mineraux et d'oligo-elements et procede pour produire des nanoparticules, des melanges de nanoparticules, des solutions nanometriques et, de fa on generale, des solutions sursaturees
AT401346B (de) Verfahren zur herstellung eines antioxidationsmittels, insbesondere zur verwendung als arzneimittel
DE2541459C3 (de) Verfahren zur Herstellung staubfreier arzneilicher Chinoxalin-1,4dioxid-Tierfuttermischungen
DE2437845A1 (de) Pharmazeutisches, dispergierbares, sitosterine enthaltendes pulver und verfahren zu seiner herstellung
WO2015192834A2 (fr) Procédé de production d'une substance consommable conçue pour se vaporiser
DE2042572B2 (de) Verfahren zur herstellung eines getraenkepulvers
EP1694139A1 (fr) Procede de production de preparations de substances minerales a constituants multiples
DE2135734A1 (de) Gewinnung von Metallen aus zusammen gesetzten Erzen
EL-Moslamy et al. Bioprocess strategies and characterization of anti-multidrug resistant human pathogens copper/copper oxide nanoparticles from citrus peel waste extracts
DE2506100A1 (de) Behandlung von rauchwaren
DE102014200922A1 (de) Verwendung von Tonmineral als Futterzusatzstoff und/oder als Ergänzungsfutter für aquatische Organismen
DE2118770A1 (de) Verfahren zur Herstellung eines Katalysators für die Oxydation von Kohlenmonoxyd zu Kohlendioxyd
Barboiu et al. Potential health risk assessment associated with heavy metal accumulation in native Urtica dioica
Jia et al. Acute and 28-day sub-acute oral toxicity evaluation of two dietary bamboo charcoal powders in Sprague-Dawley rats
Ezeokonkwo Mercy et al. Proximate composition and mineral analysis of Mucuna utilis (Velvet Bean)
Jha et al. Bhasmas as natural nanorobots: the biorelevant metal complex
EP2550872B1 (fr) Procédé de production d'une composition comprenant de l'anthocyane et compositions correspondantes
Dash et al. Pharmaceutical and Identification Study of Naga Bhasma
Girigisu et al. Comparative Study of Heavy Metals in Plant and Soil of Some Selected Medicinal Plant
Kaličanin et al. Optimization and Application of Potentiometric Stripping Analysis for Determination of Heavy Metals in the samples of Aronia melanocarpa (Michx.) Elliot
DE699574C (de) Verfahren zur Herstellung eines Arzneimittels in koerniger oder kugeliger Form
Bhatnagar et al. Comparing the physico-chemical characteristics of formulated and marketed yashada bhasma
DE3905033A1 (de) Extrakt, arzneimittel
EP1688136A1 (fr) Bioquinones hydrophiles, leur préparation et utilisation
Gentscheva et al. Determination of essential and toxic elements in berries from Bulgaria (Plovdiv region)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060616

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20070315

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110601